We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.98B
AUM Growth
+$857M
Cap. Flow
+$784M
Cap. Flow %
11.24%
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184

Top Buys

Rank Stock Value
1
QRVO icon
Qorvo
QRVO
+$153M
2
ASML icon
ASML
ASML
+$117M
3
RVMD icon
Revolution Medicines
RVMD
+$58.1M
4
META icon
Meta Platforms (Facebook)
META
+$49.6M
5
ISRG icon
Intuitive Surgical
ISRG
+$48.5M

Top Sells

Rank Stock Value
1
TER icon
Teradyne
TER
+$132M
2
QCOM icon
Qualcomm
QCOM
+$77.3M
3
ABT icon
Abbott
ABT
+$69.2M
4
BKNG icon
Booking.com
BKNG
+$67.7M
5
KLAC icon
KLA
KLAC
+$63.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Technology 29.45%
3 Communication Services 6.73%
4 Industrials 6.43%
5 Financials 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
151
Illumina
ILMN
$31B
$13.1M 0.19%
35,395
+13,814
+64% +$5.23M
WBT
152
DELISTED
Welbilt, Inc.
WBT
$13M 0.19%
548,701
+150,378
+38% +$3.56M
CP icon
153
Canadian Pacific Kansas City
CP
$78.1B
$13M 0.19%
+180,682
New +$13.2M
VOR icon
154
Vor Biopharma
VOR
$1.15B
$12.9M 0.18%
55,556
– –
ROP icon
155
Roper Technologies
ROP
$38.8B
$12.7M 0.18%
+25,846
New +$12.3M
HUM icon
156
Humana
HUM
$43.7B
$12.7M 0.18%
+27,309
New +$12.1M
IR icon
157
Ingersoll Rand
IR
$32.6B
$12.6M 0.18%
+204,112
New +$11.6M
AZO icon
158
AutoZone
AZO
$49.2B
$12.6M 0.18%
+6,000
New +$11.2M
IONS icon
159
Ionis Pharmaceuticals
IONS
$8.6B
$12.5M 0.18%
411,454
+5,993
+1% +$189K
PASG icon
160
Passage Bio
PASG
$14.4M
$12.2M 0.17%
95,751
+79,661
+495% +$13M
LOW icon
161
Lowe's Companies
LOW
$117B
$12.1M 0.17%
+47,000
New +$11.2M
TMO icon
162
Thermo Fisher Scientific
TMO
$213B
$12M 0.17%
+17,953
New +$11.2M
IGMS
163
DELISTED
IGM Biosciences
IGMS
$11.8M 0.17%
403,401
-165,608
-29% -$8.23M
IOVA icon
164
Iovance Biotherapeutics
IOVA
$1.82B
$11.8M 0.17%
618,703
+433,151
+233% +$9.54M
PLTK icon
165
Playtika
PLTK
$1.52B
$11.8M 0.17%
682,172
-404,819
-37% -$9.06M
IDYA icon
166
IDEAYA Biosciences
IDYA
$3.42B
$11.8M 0.17%
498,187
+353,808
+245% +$8.22M
SLAB icon
167
Silicon Laboratories
SLAB
$7.17B
$11.8M 0.17%
57,046
-153,338
-73% -$28.2M
FATE icon
168
Fate Therapeutics
FATE
$286M
$11.6M 0.17%
199,076
+46,119
+30% +$2.61M
STKL
169
DELISTED
SunOpta
STKL
$11.6M 0.17%
1,672,273
-1,200,841
-42% -$8.69M
PEP icon
170
PepsiCo
PEP
$190B
$11.6M 0.17%
+66,800
New +$10.9M
LUNG icon
171
Pulmonx
LUNG
$68.8M
$11.6M 0.17%
361,607
+25,294
+8% +$924K
TNET icon
172
TriNet
TNET
$3.02B
$11.6M 0.17%
121,524
+38,867
+47% +$3.88M
HCA icon
173
HCA Healthcare
HCA
$87.2B
$11.5M 0.16%
44,687
-66,132
-60% -$16.2M
SYK icon
174
Stryker
SYK
$125B
$11.5M 0.16%
42,908
+5,082
+13% +$1.33M
VG
175
DELISTED
Vonage Holdings Corporation
VG
$11.4M 0.16%
+548,700
New +$10M
5 6
7
8 9

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

Woodline Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.

  • Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
  • Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
  • Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
  • Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
  • Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.

Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.